Magnifying glass resting on two stacked orange file folders against a dark blue background

Table of Contents

H2 headings will appear here...

PBM 101

How to Evaluate PBMs for Your Pharmacy Benefit Strategy

How to Evaluate PBMs for Your Pharmacy Benefit Strategy

Portrait of SmithRx

SmithRx

Key Takeaways

  • The largest PBMs hold most of the market, yet market share alone doesn't make a PBM the right choice for your plan.

  • A leading PBM for your plan earns that label on compensation, ownership, data, clinical execution, and service.

  • Comparing bids on net cost and claim-level reporting shows which PBM delivers value beyond discounts.

At renewal or RFP time, the search for a pharmacy benefit manager (PBM) often starts with one question: who are the leading PBMs? The shortlist of PBMs may default to the best-known names, because brand recognition feels like a safe choice. Fit takes more work to assess, and it matters more. As a plan fiduciary, the employer has to defend the choice on economics and execution.

Market share can't show whether a PBM earns more when your plan spends more. The leading PBMs for your pharmacy benefit strategy are the ones whose contracts, incentives, data, and execution work in your plan's favor.

Who Are the Largest PBMs, and Does Market Share Make a PBM Leading?

The American Medical Association's 2025 analysis of PBM market concentration found that four PBMs held about 67% of the market for core PBM services in 2023. They are Optum Rx, CVS Caremark (part of CVS Health), Express Scripts, and Prime Therapeutics, and the first three are often called the Big Three.

Most lists of the top PBM companies stop at that ranking. Market share describes position and says little about a plan's net cost or the service its members receive. For an employer plan, a leading PBM is one whose contract, incentives, and operations support the plan's cost and member goals.

Employers Are Moving Away From Big Three PBMs

The Big Three's share among surveyed employers slipped from 2025 to 2026, according to the 2026 Pulse of the Purchaser report from the National Alliance of Healthcare Purchaser Coalitions.

Most employers that changed PBMs in the past year now use a PBM outside the Big Three. More movement may follow. Among Big Three clients, 55.7% are considering a PBM change in the next one to three years, compared with 31.1% of employers using other PBMs. That interest rises with employer size, and the report notes the next wave of change could come from larger purchasers.

As some employers contract outside the Big Three, benefits leaders need a way to compare PBMs built on different contract and operating models.

Five Criteria That Define a Leading PBM for Your Plan

PBM operating models differ in how they are paid, what they own, what they disclose, how they run clinical programs, and how they serve members and HR. Each difference connects to an employer outcome: plan cost, fiduciary risk, HR workload, or employee experience. Test each PBM on your shortlist against the five criteria below.

1. Contract Structure and Compensation

The first criterion is compensation: does the PBM earn more when your plan pays more? Spread pricing, retained rebates, and percentage-of-spend fees all tie PBM revenue to drug prices or volume. A fixed administrative fee doesn't change with drug price or volume; confirm that the fixed-fee PBM contract terms also rule out other revenue sources.

Ask which rebates and discounts pass through and whether the contract defines them. The Consolidated Appropriations Act, 2026 (CAA) sets a pass-through requirement for plan years beginning on or after August 3, 2028. Contracts entered, extended, or renewed on or after that date must pass 100% of rebates and similar payments to the plan. As pass-through becomes a legal floor, how each PBM is paid carries more weight.

2. Ownership and Channel Relationships

Next, look at what the PBM's parent company owns. If that includes pharmacies, specialty or mail-order operations, or rebate-contracting entities, ask how the PBM routes claims and makes formulary and pharmacy decisions. The plan's lowest net cost should govern those decisions.

Request routing rules in writing, including any affiliated-pharmacy requirement, since such requirements are where vertical integration can shape PBM incentives.

3. Data Access and Audit Rights

Confirm you can verify what the contract promises through claim-level data and audit rights. In the National Alliance's 2026 Pulse of the Purchaser survey, 23.4% of Big Three clients answered "not sure" about what is in their PBM contracts. Among employers using other PBMs, 11.7% gave that answer.

The Department of Labor (DOL) published its final PBM fee disclosure rule in the Federal Register on November 2, 2026. It covers large self-insured group health plans: employers with 100 or more employees or plans with 100 or more participants. It applies to plan years beginning on or after July 1, 2027, and fully insured plans are carved out of its detailed requirements.

PBMs must give the responsible plan fiduciary a written, dollar-based compensation disclosure before a contract is signed, extended, or renewed and every six months after. Fiduciaries can audit those disclosures; the rule addresses disclosure and audit rights only and leaves PBM pay to each contract. Employers can ask for comparable disclosures, claim-level data, and audit terms now, and review timing and scope with their counsel and benefits advisor.

4. Clinical Execution

Look for a PBM that moves members to clinically appropriate, lower-net-cost options such as generics, biosimilars, and therapeutic alternatives. The PBM's clinical team manages utilization through tools such as prior authorization and step therapy. Find out who sets the clinical criteria, who reviews requests, and how exceptions and appeals are handled.

Ask each PBM to report realized savings apart from identified opportunities, and net cost apart from list-price discounts.

5. Member and Account Service

The final criterion is service, which determines how much PBM work lands on HR and how employees experience the benefit. For member support, ask whether it is in-house or outsourced, and which response-time commitments are contractual.

For account service, clarify who the dedicated account contact is and what that person owns. Ask how the PBM plans a transition, including when members are notified and what support is in place at go-live. Write these account support and member service commitments into the contract.

How to Compare PBM Proposals in an RFP

Discount-based and pass-through bids aren't comparable at face value. One may lead with deep average wholesale price (AWP) discounts and rebate guarantees; another may pass through pharmacy costs and rebates for a separate fee.

Require every bidder to price on identical, transparent terms. Compare total net cost and per member per month (PMPM) cost after 100% of rebates, setting aside AWP discount percentages and rebate guarantees. Request sample disclosures and claim-level reports, confirm audit rights, and check that terms like "rebate," "brand," and "generic" share one definition across contracts.

Employers typically run a PBM RFP with their benefits broker or consultant, but the decision rests with the employer as plan fiduciary. Send every bidder the same PBM pricing transparency questions, starting with the core ones below:

Evaluation Area

Question to Ask Each PBM

What a Clear Answer Includes

Compensation

How are you paid, and does any revenue rise with plan drug spend?

Every revenue source, and whether each one changes with drug price or volume

Rebates

Which manufacturer rebates and fees pass through, and where does the contract say so?

A contractual definition of all rebate types, plus periodic pass-through reporting

Pricing basis

Does the plan pay what you pay the pharmacy?

Pharmacy-paid pricing or a fully disclosed spread, with identical terms across channels

Ownership and routing

Which pharmacies or rebate entities does your parent company own, and how are claims routed?

Listed affiliates and written routing rules tied to plan net cost

Data and audit

What claim-level data will we receive, and what can we audit?

Scheduled claim-level files, a defined audit scope, and sample reports

Clinical savings reporting

How do you report realized savings and identified opportunities?

Separate realized and identified figures, with net cost apart from list-price discounts

Service commitments

Who supports members, and which response times are contractual?

In-house or outsourced status, contractual response times, a named account contact, and a transition plan

This gives the employer a documented, defensible decision. Our PBM Evaluation Guide walks through it step by step.

How SmithRx Makes PBM Evaluation Easier for Employers

Comparing PBMs is hard when compensation, ownership, and data are hidden; our model makes each criterion above checkable. We pair a fixed PMPM administrative fee with 100% rebate pass-through, so our compensation doesn't rise when drug costs rise.

We don't own pharmacies. Instead of favoring affiliate entities, SmithRx's Drug Pathways Engine evaluates each claim for clinically appropriate drug options and savings programs. It compares retail, mail-order, specialty, and partner channels, such as manufacturer-direct or cost-plus pharmacies, to identify the lowest-net-cost source.

When a pathway requires action, our support teams help members take the next step. That support is in-house, so the people answering member questions know the benefit we administer. Employers and brokers can review claim-level pricing, PMPM, and pass-through rebate reporting in the SmithRx Partner Portal.

Employers can compare any bid, ours included, on the net cost and PMPM measures above. SmithRx clients see 20%+ lower PMPM than the industry benchmark, based on 2025 data.

New disclosure and reporting rules will make more PBM compensation and rebate data visible over the next few plan years. Employers who write disclosure, data, and audit terms into their next contract and compare bids on net cost can judge fit with that data in hand. To see how your current pricing compares today, request a repricing analysis of your historical claims.

Frequently Asked Questions

How is a pass-through PBM different from a fixed-fee PBM?

Pass-through describes how drug costs and rebates flow to the plan, while a fixed fee describes how the PBM is paid. A contract can include one without the other, so confirm both terms in writing.

Should employers carve pharmacy benefits out of their medical plan?

Yes, if your plan is self-funded; fully insured plans generally get pharmacy through the carrier. A self-funded employer carries claims risk and contracts directly, and carving pharmacy out of a bundled medical plan lets it bid pharmacy separately and see rebate and pricing detail the carrier may not show.

When should an employer start a PBM RFP?

We recommend starting at least 10 to 12 months before your current contract expires. That leaves time to compare bids and plan the transition before go-live.

Does the CAA's pass-through requirement apply to my current PBM contract?

Not until it's renewed or extended. The requirement applies to contracts entered, extended, or renewed on or after August 3, 2028, for plan years beginning on or after that date, so review renewal timing with your counsel and benefits advisor.

Portrait of SmithRx
SmithRx

SmithRx is the #1 Modern PBM, relentlessly focused on eliminating the conflicts and complexity of legacy pharmacy benefits. Built on radical transparency and fiduciary alignment, we empower employers to take control of their pharmacy spend and experience with our 100% pass-through model.

One orange magnifying glass stands out among a group of white magnifying glasses on a pale blue background.

PBM 101

How to Evaluate PBM Performance: Key Metrics

Meeting guarantees is not proof of value. Score your PBM on verifiable net cost, clinical care, and service.

date

One orange magnifying glass stands out among a group of white magnifying glasses on a pale blue background.

PBM 101

How to Evaluate PBM Performance: The Metrics, Data, and Contract Rights That Matter

Meeting guarantees is not proof of value. Score your PBM on verifiable net cost, clinical care, and service.

date

One orange magnifying glass stands out among a group of white magnifying glasses on a pale blue background.

PBM 101

How to Evaluate PBM Performance: The Metrics, Data, and Contract Rights That Matter

Meeting guarantees is not proof of value. Score your PBM on verifiable net cost, clinical care, and service.

date

Pink polka-dot piggy bank tipped forward toward a small pile of coins

PBM 101

Transparent vs. 100% Pass-Through PBM Contracts

In this article, we define the difference between transparent and pass-through contracts. While often used interchangeably, they represent two distinct aspects of PBM operations. 

date

Pink polka-dot piggy bank tipped forward toward a small pile of coins

PBM 101

Unraveling PBM Complexity: Transparent PBM Contracts vs 100% Pass-Through Contracts

In this article, we define the difference between transparent and pass-through contracts. While often used interchangeably, they represent two distinct aspects of PBM operations. 

date

Pink polka-dot piggy bank tipped forward toward a small pile of coins

PBM 101

Unraveling PBM Complexity: Transparent PBM Contracts vs 100% Pass-Through Contracts

In this article, we define the difference between transparent and pass-through contracts. While often used interchangeably, they represent two distinct aspects of PBM operations. 

date

PBM 101

What Is a Fiduciary-Aligned PBM? A Guide for Employer Plan Sponsors

“Fiduciary-aligned” is in almost every PBM proposal. Here’s how plan sponsors can test the claim.

date

PBM 101

What Is a Fiduciary-Aligned PBM? A Guide for Employer Plan Sponsors

“Fiduciary-aligned” is in almost every PBM proposal. Here’s how plan sponsors can test the claim.

date